Skip to main content
NewslettersWatchlist

Mckesson Corp(MCK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low536.57
Day High539.90
Open:538.19
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Retreat as Bond Yields Surge on US Price Pressures
Barchart
Stocks Tumble as Sticky US CPI Curbs the Outlook for Fed Rate Cuts
Barchart
Stocks Sink as US CPI Tops Forecasts
Motley Fool
McKesson (MCK) Q3 2024 Earnings Call Transcript
Barchart
S&P Futures Tick Higher Ahead of More Fed Speak, Disney Earnings on Tap
Barchart
3 Healthcare Stocks Ready to Soar in 2024
Motley Fool
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
Motley Fool
McKesson (MCK) Q2 2024 Earnings Call Transcript
Barchart
3 Mega-Cap Stocks To Buy Before They're Worth $1 Trillion
Barchart
Chart of the Day: McKesson - Healthcare Star
MarketBeat
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
Barchart
Stocks Sink as the Rout in Government Bonds Deepens
Barchart
Stocks Tumble as Bond Yields Soar on U.S. Labor Strength and Hawkish Fed
Barchart
Markets Today: Stocks Decline as Bond Yields Soar
Barchart
Stocks Recover Early Losses on Soft Landing Optimism for the U.S. Economy
The Globe and Mail
Six health care stock picks to play defence in times of market volatility
MarketBeat
3 Low P/E Stock ETFs for Hungry Value Investors
Motley Fool
Warren Buffett Just Dumped These 3 Dividend Stocks. Should You?
Barchart
Rising Bond Yields Pressure Stock Prices
Barchart
Stocks Lower as Bond Yields Rise
PR Newswire
Genpact Extends Relationship to Transform McKesson's Finance Operations for Enhanced Service and Competitive Growth
Motley Fool
Here Are All 5 Stocks Warren Buffett and His Team Bought in the Second Quarter -- and the 7 Stocks Berkshire Hathaway Sold
Barchart
Stocks Weighed Down by Higher Bond Yields
Motley Fool
McKesson (MCK) Q1 2024 Earnings Call Transcript
The Globe and Mail
11 U.S. stocks to seize the underperformance of the Health Care sector
Barchart
Markets Today: Tech Stocks Gain on Strength in Tesla
Motley Fool
2 Best Buffett Stocks to Buy for the Long Haul
Barchart
Stocks Post Modest Gains as Regional Bank Stocks Rally
Motley Fool
3 Healthcare Stocks That Would Have Doubled Your Investment in 5 Years
Barchart
Stocks Finish Higher as Negotiators Inch Toward a Debt-Ceiling Agreement
Motley Fool
If You Invested $20,000 in McKesson in 2018, This Is How Much You Would Have Today
Motley Fool
Worried About a Recession? 2 Safe Stocks to Buy Now

Profile

McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.